Better Therapeutics, Inc. announced that Frank Karbe will join the company as Chief Executive Officer starting July 5, 2022. Current CEO and company co-founder, Kevin Appelbaum, will continue to serve in that role until then. Frank is a widely experienced senior executive, serving most recently as President and Chief Financial Officer of Myovant Sciences, where he led the company's efforts to raise approximately $2 billion in capital and oversaw its evolution from a private start-up organization to a publicly listed commercial-stage company with two approved and marketed products.

He also served for over a decade as Executive Vice President and Chief Financial Officer at Exelixis, Inc., where he drove the biopharma company's transformation from discovery to commercialization. Earlier in his career, he worked as an investment banker for Goldman Sachs & Co. focusing on corporate finance and mergers and acquisitions in the life sciences industry.